CD4 and blue cone monochromacy: In conclusion, we demonstrated robust S-reactive CD4+ and CD8+ T lymphocyte responses with TCM and TEM phenotypes in all BCM patients after two doses of the mRNA vaccine, which could be suggestive of the establishment of long-lived immunity.